Perrigo Company plc, founded in 1887 and headquartered in Dublin, Ireland, specializes in providing high-quality healthcare products. The company primarily focuses on over-the-counter consumer goods, including nutritional products, personal care items, and generic pharmaceuticals.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| PRGO 5.30% - USDPerrigo Company plc | United States | — | 5.300 | 4.54 |
| PRGO 5.30% 2043-11-15 USDPerrigo Company plc | United States | 2043-11-15 | 5.300 | 8.32 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Perrigo has a history of bond issuances that began in the early 2000s to support its growth strategies, including acquisitions. A notable issuance occurred in 2015 when Perrigo raised $1.5 billion to finance its acquisition of Omega Pharma. Currently, the company's bonds yield in line with industry averages, reflecting investor confidence amid a competitive landscape, particularly with their 10-year notes recently yielding around 4.5%. Notably, some bonds have unique features such as call options, allowing for early redemption, which can be attractive during periods of declining interest rates.